Pollack A - Search Results

1

Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.

Colletier PJ, Ashoori F, Cowen D, Meyn RE, Tofilon P, Meistrich ME, Pollack A. Colletier PJ, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1507-12. doi: 10.1016/s0360-3016(00)01409-7. Int J Radiat Oncol Biol Phys. 2000. PMID: 11121656

2

Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer.

Chyle V, Pollack A, Czerniak B, Stephens LC, Zagars GK, Terry NH, Meyn RE. Chyle V, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):281-7. doi: 10.1016/0360-3016(96)00089-2. Int J Radiat Oncol Biol Phys. 1996. PMID: 8635934

3

The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.

Pollack A, Ashoori F, Sikes C, Joon DL, von Eschenbach AC, Zagars GK, Meistrich ML. Pollack A, et al. Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):153-8. doi: 10.1016/s0360-3016(99)00387-9. Int J Radiat Oncol Biol Phys. 2000. PMID: 10656387

4

Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy.

Cowen D, Salem N, Ashoori F, Meyn R, Meistrich ML, Roth JA, Pollack A. Cowen D, et al. Among authors: pollack a. Clin Cancer Res. 2000 Nov;6(11):4402-8. Clin Cancer Res. 2000. PMID: 11106260

5

Lack of prostate cancer radiosensitization by androgen deprivation.

Pollack A, Salem N, Ashoori F, Hachem P, Sangha M, von Eschenbach AC, Meistrich ML. Pollack A, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1002-7. doi: 10.1016/s0360-3016(01)01750-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11704324

6

Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth.

Kaminski JM, Hanlon AL, Joon DL, Meistrich M, Hachem P, Pollack A. Kaminski JM, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):24-8. doi: 10.1016/s0360-3016(03)00539-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12909211

7

Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination.

Mu Z, Hachem P, Agrawal S, Pollack A. Mu Z, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):336-43. doi: 10.1016/j.ijrobp.2003.09.029. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751501

8

Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.

Nguyen KH, Hachem P, Khor LY, Salem N, Hunt KK, Calkins PR, Pollack A. Nguyen KH, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):238-46. doi: 10.1016/j.ijrobp.2005.04.033. Int J Radiat Oncol Biol Phys. 2005. PMID: 15993550 Free PMC article.

9

Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.

Udayakumar TS, Stoyanova R, Hachem P, Ahmed MM, Pollack A. Udayakumar TS, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):549-58. doi: 10.1016/j.ijrobp.2010.08.013. Int J Radiat Oncol Biol Phys. 2011. PMID: 21195876 Free PMC article.

10

Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.

Khoo VS, Pollack A, Cowen D, Joon DL, Patel N, Terry NH, Zagars GK, von Eschenbach AC, Meistrich ML, Troncoso P. Khoo VS, et al. Among authors: pollack a. Prostate. 1999 Nov 1;41(3):166-72. doi: 10.1002/(sici)1097-0045(19991101)41:3<166::aid-pros3>3.0.co;2-e. Prostate. 1999. PMID: 10517874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

969 results

Search Page

Filters